EPT Stats & Data

EPT's original synthesis date remains unknown. The compound first appeared for sale on the online research chemical market in 2016, emerging as what appears to be an entirely novel product of clandestine drug design rather than a compound derived from academic or pharmaceutical research. Unlike many psychedelic tryptamines, EPT was not included in Alexander Shulgin's influential book "TiHKAL" (Tryptamines I Have Known and Loved), and the substance has no documentation in the scientific literature. EPT remains a rarely encountered psychedelic with a very limited history of human use. The compound has been identified in illicit products in Japan, though it has otherwise received minimal attention within either research contexts or broader psychedelic culture.

The toxicity and long-term health effects of recreational EPT use have not been studied in any scientific context and the exact toxic dose is unknown. This is because EPT is a research chemical with a very limited history of human usage. Anecdotal evidence suggests that there are no negative health effects attributed to simply trying EPT by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption. It is strongly recommended that one use harm reduction practices when using this substance.